ForumDosing & Titration

Semaglutide gray to dr prescribed Tirzepatide

9 replies7 peopleMay 21, 2026☆ Follow
Summary

How to switch from gray market semaglutide to tirzepatide when waiting on insurance approval for a pre-diabetic patient

Participants recommend moving directly to gray tirzepatide rather than continuing semaglutide, citing fewer side effects and better results overall. The low sema dose can be swapped without a long washout once recent nausea clears, and gray supply provides backup if insurance denies or later drops coverage. Pre-diabetes alone rarely qualifies for insurance payment of tirzepatide even with additional conditions present.

What this discussion establishesWhere people disagree

Whether to pause semaglutide immediately or continue briefly while awaiting insurance decision, and how strictly pre-diabetes plus comorbidities must be documented before any coverage chance exists

Still open

Exact timing and method for switching doses without overlapping side effects, plus final insurance outcome

Nothing here is advice.

9 replies · 7 people
CopperLedger65archiveopening postMay 21

My wife began semaglutide from unofficial sources, but her physician prefers starting tirzepatide. The doctor does not know about the recent semaglutide use. We talked about the advantages and disadvantages of each option, and we filed a request with insurance for tirzepatide coverage. A decision is expected by the end of June. Looking for input on how to handle the transition. Should we stop the current medication right away even though coverage is not assured, begin tirzepatide unofficially now and move to a prescription later if possible, or stay with unofficial supply if coverage is denied?

SharpCinder28archiveMay 21

How is she responding to sema so far? When did she begin, what dose is she on, and what are her targets for weight loss? Any side effects or progress noted? Tirzepatide is generally viewed as the stronger option here, with reduced nausea and quicker improvements in labs and weight. Most people in similar situations see no reason to begin with sema anymore. Extra sema can still be kept as backup since it stays stable longer.

CopperLedger65archiveMay 21
↳ replying to @SharpCinder28

She has been on it for two weeks at a split dose of 0.5 mg. We chose semaglutide because friends had success with the branded version. Nausea lasts about two days after each shot. The doctor also stated tirzepatide would be the preferred medication. Her aim is a 20-25 lb loss plus better A1C numbers that currently sit in the 6-7 range. She has dropped three pounds, though diet changes may account for some of that. I am leaning toward switching her to tirzepatide this week and continuing with unofficial supply until we know about insurance.

LevelThistle44archiveMay 21

I would avoid sema entirely and go straight to unofficial tirzepatide, though that choice could affect later insurance approval chances. Pre-diabetes by itself is probably not sufficient for my plan to pay for tirzepatide.

WryFenwick45archiveMay 21

The current dose might already be high for sema. Could you drop to 0.25 mg once weekly while waiting to see if the tirzepatide prescription comes through? Will you still receive tirzepatide if insurance refuses to cover it?

CopperLedger65archiveMay 21
↳ replying to @WryFenwick45

I will talk it over with her tonight. She relies on me for the research since I have experience with peptides over the past couple of years, though I moved straight to another GLP option myself. Her friends success with sema made it seem like a reasonable first step for comparison. We share the same doctor, and I spoke with him yesterday about these medications. He strongly favored tirzepatide given her full history. I plan to ask her about switching based on that advice and any forum input on the best way to do it. Should we stop sema for a while first or simply replace the next scheduled dose? I tried lowering to 0.25 mg weekly but she wants to continue as expected some side effects. Once we switch to tirzepatide we intend to stay with it regardless of insurance status because unofficial options keep the cost manageable compared to pharmacy pricing.

CopperCinder12archiveMay 23

Without strong insurance they will usually require the lowest cost GLP-1 option first if any coverage is offered, often the oral form of semaglutide.

CopperSignal27archiveMay 23

A direct change to tirzepatide should work fine since the sema dose remains low and side effects are already appearing. Tirzepatide at a starting weekly amount of 2.5 mg is unlikely to cause more nausea than the current sema level. It makes sense to let any existing nausea fade, perhaps waiting four to six days after the last sema shot. Even tiny sema amounts caused me noticeably more nausea than much higher tirzepatide doses. Gray supply removes dependence on insurance rule changes that have affected many users in the past.

CopperLedger65archiveMay 23
↳ replying to @CopperSignal27

Thanks for describing your own experience with both. She is having trouble eating even at this low sema dose because of nausea, so we will switch next week once the new tirzepatide arrives. Waiting until the sema-related nausea passes before adding the new medication seems wise so we can tell the difference in effects. Did you notice any side effects from tirzepatide? On the insurance versus unofficial question, we will keep tirzepatide available in case coverage never happens or gets removed later.

WarmMeadow92archiveMay 23
↳ replying to @LevelThistle44

I agree that insurance approval looks doubtful when only pre-diabetes is involved. My own attempts for branded tirzepatide were turned down repeatedly despite pre-diabetes, high BMI, sleep apnea, and borderline cholesterol, even after an appeal. Once a medication is excluded from a plan there is no coverage possible. Moving to unofficial tirzepatide is the practical route.

Related discussions

Add your experience

If you have tried it, this topic is still open. Sign in to reply — it takes a minute.